Section 505(j) 21 U.S.C. 355(j) sets forth the process by which would-be marketers of generic drugs can file Abbreviated New Drug Applications (ANDAs) to seek FDA approval of the generic.
Food and Drug Administration | Drug Enforcement Administration | drug | Food and Drug Administration (United States) | Application software | Illegal drug trade | cannabis (drug) | Recreational drug use | application software | Shoppers Drug Mart | application | Psychoactive drug | National Institute on Drug Abuse | Drug rehabilitation | Drug Abuse Resistance Education | Cannabis (drug) | Application programming interface | Pure Food and Drug Act | Drug withdrawal | drug lord | Application-specific integrated circuit | Wireless Application Protocol | Mobile application development | Web application | psychoactive drug | Pharmaceutical drug | pharmaceutical drug | Federal Food, Drug, and Cosmetic Act | Drug Wars: The Camarena Story | Drug |